The Simplesa Protocol is a nutritional supplement regimen specifically formulated for people suffering with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig’s Disease). The formulation is based on the Deanna Protocol*, which has been shown to improve patient health and reduce the progression of symptoms. The Simplesa Protocol includes 27 individual ingredients simplified into seven products: AAKG+ Core Powder; AM and PM Blends; Alpha-Ketoglutarate; Liposomal Glutathione; 5-hydroxytryptophan (5-HTP); and Caprylic Acid. The Simplesa Protocol streamlines treatment as much as possible, making it easy for patients and caregivers alike, and it is formulated to recapture the potency and effectiveness of early versions of the Deanna Protocol*.
The Simplesa Protocol uses an all-inclusive approach and has been formulated to include many potentially helpful ingredients that have shown to improve ALS symptoms, improve physical/mental functioning, and/or slow progression of the disease. All ingredients have been thoroughly researched and scientifically formulated to meet pharmaceutical grade requirements.

Simplesa products significantly simplifies following the Deanna Protocol* and provides for cost savings when compared to purchasing the various ingredients individually. Until now the various components of the Deanna Protocol had to be purchased and taken separately, but the introduction of the Simplesa products marks the first time ever that PALS following the Deanna Protocol have nutritional supplements specifically tailored to their needs.